Filed: 2/17/2026ACC: 0001214659-26-001871
📋 What this filing means
TCG CROSSOVER MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 43 equity positions with a total reported market value of $3.02B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
43
Positions
$3.02B
Total AUM (reported)
142.38M
Total Shares
Allocation by class
COMM$1.87B62.0%
ADRS$1.15B38.0%
Portfolio Concentration
Top 3$1.32B43.7%
4–10$624.18M20.7%
11–25$807.47M26.7%
Rest$270.19M8.9%
Top 3 weight
43.7%
Top 10 weight
64.3%
Voting Authority Distribution
Total shares with voting rights: 142.38M
Sole
Full voting authority
142.38M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole43
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings43
Rows:
ABIVAX SA AMERICAN DEPOSITARY SHARES
SOLEShares7.11M
TypeSH
Market value$959.03M
31.74%
Sole
7.11M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares5.87M
TypeSH
Market value$208.44M
6.90%
Sole
5.87M
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares3.67M
TypeSH
Market value$152.39M
5.04%
Sole
3.67M
Shared
0.00
None
0.00
TANGO THERAPEUTICS INC
SOLEShares12.76M
TypeSH
Market value$113.07M
3.74%
Sole
12.76M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares4.29M
TypeSH
Market value$107.20M
3.55%
Sole
4.29M
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares4.62M
TypeSH
Market value$90.27M
2.99%
Sole
4.62M
Shared
0.00
None
0.00
RAPT THERAPEUTICS INC
SOLEShares2.58M
TypeSH
Market value$87.47M
2.89%
Sole
2.58M
Shared
0.00
None
0.00
TYRA BIOSCIENCES INC
SOLEShares2.90M
TypeSH
Market value$76.19M
2.52%
Sole
2.90M
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares6.24M
TypeSH
Market value$75.43M
2.50%
Sole
6.24M
Shared
0.00
None
0.00
SAVARA INC
SOLEShares12.36M
TypeSH
Market value$74.54M
2.47%
Sole
12.36M
Shared
0.00
None
0.00
MONTE ROSA THERAPEUTICS INC
SOLEShares4.62M
TypeSH
Market value$72.48M
2.40%
Sole
4.62M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares5.74M
TypeSH
Market value$69.69M
2.31%
Sole
5.74M
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares1.68M
TypeSH
Market value$69.09M
2.29%
Sole
1.68M
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares3.57M
TypeSH
Market value$65.27M
2.16%
Sole
3.57M
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares920.86K
TypeSH
Market value$64.05M
2.12%
Sole
920.86K
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares1.90M
TypeSH
Market value$62.26M
2.06%
Sole
1.90M
Shared
0.00
None
0.00
FULCRUM THERAPEUTICS INC
SOLEShares5.25M
TypeSH
Market value$59.38M
1.97%
Sole
5.25M
Shared
0.00
None
0.00
LIQUIDIA TECHNOLOGIES INC
SOLEShares1.71M
TypeSH
Market value$58.98M
1.95%
Sole
1.71M
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares4.63M
TypeSH
Market value$52.29M
1.73%
Sole
4.63M
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares1.66M
TypeSH
Market value$42.22M
1.40%
Sole
1.66M
Shared
0.00
None
0.00
KODIAK SCIENCES INC
SOLEShares1.45M
TypeSH
Market value$40.42M
1.34%
Sole
1.45M
Shared
0.00
None
0.00
ADC THERAPEUTICS SA
SOLEShares11.39M
TypeSH
Market value$40.21M
1.33%
Sole
11.39M
Shared
0.00
None
0.00
LB PHARMACEUTICALS INC
SOLEShares1.75M
TypeSH
Market value$38.84M
1.29%
Sole
1.75M
Shared
0.00
None
0.00
XENCOR INC
SOLEShares2.45M
TypeSH
Market value$37.54M
1.24%
Sole
2.45M
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares436.47K
TypeSH
Market value$34.77M
1.15%
Sole
436.47K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ABIVAX SA AMERICAN DEPOSITARY SHARESSOLE | ADRS | 7.11M | SH | $959.03M 31.74% | 7.11M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COMM | 5.87M | SH | $208.44M 6.90% | 5.87M | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COMM | 3.67M | SH | $152.39M 5.04% | 3.67M | 0.00 | 0.00 |
TANGO THERAPEUTICS INCSOLE | COMM | 12.76M | SH | $113.07M 3.74% | 12.76M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | ADRS | 4.29M | SH | $107.20M 3.55% | 4.29M | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COMM | 4.62M | SH | $90.27M 2.99% | 4.62M | 0.00 | 0.00 |
RAPT THERAPEUTICS INCSOLE | COMM | 2.58M | SH | $87.47M 2.89% | 2.58M | 0.00 | 0.00 |
TYRA BIOSCIENCES INCSOLE | COMM | 2.90M | SH | $76.19M 2.52% | 2.90M | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COMM | 6.24M | SH | $75.43M 2.50% | 6.24M | 0.00 | 0.00 |
SAVARA INCSOLE | COMM | 12.36M | SH | $74.54M 2.47% | 12.36M | 0.00 | 0.00 |
MONTE ROSA THERAPEUTICS INCSOLE | COMM | 4.62M | SH | $72.48M 2.40% | 4.62M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COMM | 5.74M | SH | $69.69M 2.31% | 5.74M | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COMM | 1.68M | SH | $69.09M 2.29% | 1.68M | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COMM | 3.57M | SH | $65.27M 2.16% | 3.57M | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | ADRS | 920.86K | SH | $64.05M 2.12% | 920.86K | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COMM | 1.90M | SH | $62.26M 2.06% | 1.90M | 0.00 | 0.00 |
FULCRUM THERAPEUTICS INCSOLE | COMM | 5.25M | SH | $59.38M 1.97% | 5.25M | 0.00 | 0.00 |
LIQUIDIA TECHNOLOGIES INCSOLE | COMM | 1.71M | SH | $58.98M 1.95% | 1.71M | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COMM | 4.63M | SH | $52.29M 1.73% | 4.63M | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COMM | 1.66M | SH | $42.22M 1.40% | 1.66M | 0.00 | 0.00 |
KODIAK SCIENCES INCSOLE | COMM | 1.45M | SH | $40.42M 1.34% | 1.45M | 0.00 | 0.00 |
ADC THERAPEUTICS SASOLE | COMM | 11.39M | SH | $40.21M 1.33% | 11.39M | 0.00 | 0.00 |
LB PHARMACEUTICALS INCSOLE | COMM | 1.75M | SH | $38.84M 1.29% | 1.75M | 0.00 | 0.00 |
XENCOR INCSOLE | COMM | 2.45M | SH | $37.54M 1.24% | 2.45M | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COMM | 436.47K | SH | $34.77M 1.15% | 436.47K | 0.00 | 0.00 |
Page 1 of 2